Interaction Guide · Research summary

Can I take Magnesium with Fludrocortisone?

Review Magnesium with Fludrocortisone: absorption and effectiveness, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

An absorption problem with fludrocortisone and magnesium is not established by the available direct evidence. If the product is an antacid, ask the pharmacist to apply its specific timing advice.

What this answer covers

Oral fludrocortisone with magnesium. Relevant studies used particular antacid mixtures and other corticosteroids; elemental nutrient entries are not identical to antacid formulations.

Supplement or preparation
Magnesium
Medication ingredient
fludrocortisone

Which treatment this applies to

This review concerns oral fludrocortisone acetate tablets, the preparation used clinically for fludrocortisone’s mineralocorticoid effects. Adrenal replacement and treatment of orthostatic symptoms require distinct salt and monitoring plans. It does not establish free-base dose equivalence or effects of other routes.

What the studies actually tested

One small study found reduced prednisolone exposure after prednisone with aluminum/magnesium hydroxide mixtures. Other prednisone or prednisolone studies found no significant antacid effect. These are different corticosteroids and mixed antacid products, not direct fludrocortisone trials.

Distinguish an antacid from a nutrient

Tell the pharmacist the compound, formulation and reason for use. An elemental aluminum or magnesium listing does not identify an antacid, its neutralizing capacity or its full ingredient mixture. Findings about a mixture cannot isolate the contribution of each ingredient or establish the same effect for every supplement.

Use the applicable product instructions

A BC Women’s Hospital fludrocortisone handout advises taking it two hours after antacids in its POTS/hypotension program. This is precautionary guidance, not a trial proving the interval prevents this exact interaction. Confirm the schedule with your pharmacist and keep prescribed steroid treatment.

Evidence and practical considerations

Absorption & effectiveness

Other-corticosteroid antacid studies are conflicting and do not prove reduced fludrocortisone absorption with every magnesium product.

Exact scope
Oral fludrocortisone with magnesium. Relevant studies used particular antacid mixtures and other corticosteroids; elemental nutrient entries are not identical to antacid formulations. with Exact RxNorm 4452 IN fludrocortisone. Clinical label evidence is oral fludrocortisone acetate 0.1 mg tablets, the ester preparation used for mineralocorticoid effects; this is an explicit active-moiety bridge, not a free-base dose equivalence.
Medication form and route
Oral

What remains uncertain

  • No direct exact-drug nutrient/antacid PK trial identified. Conflicting other-steroid studies and preparation-specific timing guidance cannot establish a universal absorption reduction.

Factors that may matter: Exact oral preparation and dose; Treatment duration and indication; Blood pressure and electrolyte status; Other medicines.

Research conclusion: insufficient evidence · Evidence assessment: low

Read the supporting source summaries

Source 1: Current prescribing information

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed Fludrocortisone acetate oral tablets.

Small oral doses cause sodium retention, increased potassium excretion and BP elevation. Monitoring of salt intake, BP, weight and electrolytes is advised; replacement decisions are individualized.

How this applies: Exact ingredient and specified formulation. Exact RxNorm 4452 IN fludrocortisone. Clinical label evidence is oral fludrocortisone acetate 0.1 mg tablets, the ester preparation used for mineralocorticoid effects; this is an explicit active-moiety bridge, not a free-base dose equivalence.

Acetate formulation bridge does not establish other routes or dose equivalence. Mineralocorticoid replacement is not automatically the systemic glucocorticoid exposure in osteoporosis guidelines.

Source 2: Original clinical research

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Five healthy volunteers and twelve patients with chronic active liver disease.

Measured prednisolone peaks and exposure were reduced with mixtures.

How this applies: Applicable only to the stated preparation, route and endpoints; other-drug evidence is indirect.

Abstract-only; prednisone/prednisolone is not fludrocortisone. Mixed salts do not isolate aluminum or magnesium effects, and liver disease changes applicability.

Source 3: Original clinical research

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Human prednisone-antacid PK study.

No significant difference in peak, AUC or time to peak.

How this applies: Applicable only to the stated preparation, route and endpoints; other-drug evidence is indirect.

Abstract-only; different corticosteroid and formulations; no proof of exact-pair safety.

Source 4: Original clinical research

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Nineteen healthy volunteers; six nonfasting participants had repeat antacid co-use.

Food altered absorption rate but not extent; antacid did not significantly change parameters in the nonfasting subgroup.

How this applies: Applicable only to the stated preparation, route and endpoints; other-drug evidence is indirect.

Abstract-only; small subgroup and different corticosteroid, not a validated fludrocortisone spacing experiment.

Source 5: Original hospital medication guidance

bcwomens.ca · Source check Sep 10, 2026

Population: Patients receiving oral fludrocortisone for POTS or neurally mediated hypotension.

Advises potassium/kidney monitoring and taking fludrocortisone two hours after antacids.

How this applies: Exact drug guidance with antacid and indication boundaries.

Clinical handout, not measured absorption or a trial validating the interval; not every magnesium supplement or aluminum exposure.

Source 6: Medication terminology

rxnav.nlm.nih.gov · Source check Sep 10, 2026

Population: Terminology.

fludrocortisone is IN.

How this applies: Exact ingredient.

Not clinical evidence.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Sources checked and article drafted.
Research summary published

Article revision: 1e4976a4cbc31014

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.